Cargando…

COVID‐19 and children: medical impact and collateral damage

Children mostly experience mild SARS‐CoV‐2 infections, but the extent of paediatric COVID‐19 disease differs between geographical regions and the distinct pandemic waves. Not all infections in children are mild, some children even show a strong inflammatory reaction resulting in a multisystem inflam...

Descripción completa

Detalles Bibliográficos
Autor principal: Brüssow, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966019/
https://www.ncbi.nlm.nih.gov/pubmed/35182108
http://dx.doi.org/10.1111/1751-7915.14018
_version_ 1784678565248237568
author Brüssow, Harald
author_facet Brüssow, Harald
author_sort Brüssow, Harald
collection PubMed
description Children mostly experience mild SARS‐CoV‐2 infections, but the extent of paediatric COVID‐19 disease differs between geographical regions and the distinct pandemic waves. Not all infections in children are mild, some children even show a strong inflammatory reaction resulting in a multisystem inflammatory syndrome. The assessments of paediatric vaccination depend on the efficacy of protection conferred by vaccination, the risk of adverse reactions and whether children contribute to herd immunity against COVID‐19. Children were also the target of consequential public health actions such as school closure which caused substantial harm to children (educational deficits, sociopsychological problems) and working parents. It is, therefore, important to understand the transmission dynamics of SARS‐CoV‐2 infections by children to assess the efficacy of school closures and paediatric vaccination. The societal restrictions to contain the COVID‐19 pandemic had additional negative effects on children’s health, such as missed routine vaccinations, nutritional deprivation and lesser mother–child medical care in developing countries causing increased child mortality as a collateral damage. In this complex epidemiological context, it is important to have an evidence‐based approach to public health approaches. The present review summaries pertinent published data on the role of children in the pandemic, whether they are drivers or followers of the infection chains and whether they are (after elderlies) major sufferers or mere bystanders of the COVID‐19 pandemic.
format Online
Article
Text
id pubmed-8966019
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89660192022-04-05 COVID‐19 and children: medical impact and collateral damage Brüssow, Harald Microb Biotechnol Lilliput Children mostly experience mild SARS‐CoV‐2 infections, but the extent of paediatric COVID‐19 disease differs between geographical regions and the distinct pandemic waves. Not all infections in children are mild, some children even show a strong inflammatory reaction resulting in a multisystem inflammatory syndrome. The assessments of paediatric vaccination depend on the efficacy of protection conferred by vaccination, the risk of adverse reactions and whether children contribute to herd immunity against COVID‐19. Children were also the target of consequential public health actions such as school closure which caused substantial harm to children (educational deficits, sociopsychological problems) and working parents. It is, therefore, important to understand the transmission dynamics of SARS‐CoV‐2 infections by children to assess the efficacy of school closures and paediatric vaccination. The societal restrictions to contain the COVID‐19 pandemic had additional negative effects on children’s health, such as missed routine vaccinations, nutritional deprivation and lesser mother–child medical care in developing countries causing increased child mortality as a collateral damage. In this complex epidemiological context, it is important to have an evidence‐based approach to public health approaches. The present review summaries pertinent published data on the role of children in the pandemic, whether they are drivers or followers of the infection chains and whether they are (after elderlies) major sufferers or mere bystanders of the COVID‐19 pandemic. John Wiley and Sons Inc. 2022-02-19 /pmc/articles/PMC8966019/ /pubmed/35182108 http://dx.doi.org/10.1111/1751-7915.14018 Text en © 2022 The Authors. Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Lilliput
Brüssow, Harald
COVID‐19 and children: medical impact and collateral damage
title COVID‐19 and children: medical impact and collateral damage
title_full COVID‐19 and children: medical impact and collateral damage
title_fullStr COVID‐19 and children: medical impact and collateral damage
title_full_unstemmed COVID‐19 and children: medical impact and collateral damage
title_short COVID‐19 and children: medical impact and collateral damage
title_sort covid‐19 and children: medical impact and collateral damage
topic Lilliput
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966019/
https://www.ncbi.nlm.nih.gov/pubmed/35182108
http://dx.doi.org/10.1111/1751-7915.14018
work_keys_str_mv AT brussowharald covid19andchildrenmedicalimpactandcollateraldamage